[Clinical tests of topical preparations containing betamethasone 17-benzoate and the same associated with 5,7-dichloro-8-hydroxyquinoline (chloroxine)].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000891:Anti-Infective Agents, Local; D000935:Antifungal Agents; D001623:Betamethasone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D002739:Chloroquinolinols / Q000627:therapeutic use*; D004338:Drug Combinations; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D006912:Hydroxyquinolines / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D012871:Skin Diseases / Q000188:drug therapy*
D000891:Anti-Infective Agents, Local; D000935:Antifungal Agents; D002739:Chloroquinolinols; D004338:Drug Combinations; D006912:Hydroxyquinolines; C004357:chloroxine; C015706:betamethasone benzoate; D001623:Betamethasone
Sperimentazione clinica di preparazioni per uso topico contenenti betametasone-17-benzoato e lo stesso associato a 5,7-dicloro-8-idrossichinolina (clorossina).